1. Introduction {#S1}
===============

Insulin is synthesized in pancreatic β cells and increases in plasma glucose levels stimulate the release of insulin from the pancreas into the circulation. Once released into circulation, insulin binds to and activates insulin receptors in the periphery and thereby stimulates several signaling cascades, including the PI-3 kinase/Akt pathway and the MEK pathway, the former of which is responsible for insulin-stimulated translocation of glucose transporter 4 (GLUT4) to the plasma membrane. Through the activation of these pathways, insulin stimulates glucose uptake from blood into peripheral tissues like muscle and fat. For many years it was assumed that the activities of insulin were restricted to the periphery, and as such it was erroneously assumed that the brain should be considered an 'insulin insensitive' organ. The initial acceptance that insulin mediates activities in the CNS came from studies demonstrating that insulin plays important roles in homeostatic regulation mediated by the hypothalamus ([@R67]). However, more recently it has become clear that the actions of insulin are more widespread in the CNS, and are a critical part of normal development ([@R14]), as well as plasticity throughout adulthood ([@R61]).

In addition to peripheral effects, insulin crosses the blood-brain barrier via a saturable transport system ([@R6]). The current consensus in the field is that the insulin gene is not expressed in adult brain, and thus neural actions of insulin are mediated by active transport of peripheral insulin into the CNS ([@R3]; [@R66]). However, debate remains in part because of changes in insulin polypeptide genes have been observed in disease states including Alzheimer\'s Disease ([@R74]). While insulin receptors are expressed in the CNS and stimulate GLUT4 translocation in the brain ([@R28]), it is very likely that the majority of glucose uptake in the brain is insulin-independent ([@R52]). Instead of regulating glucose metabolism, the current evidence supports the concept that insulin facilitates critical brain functions ranging from metabolism and feeding, to cognition and motivation. These diverse physiological and behavioral activities highlight the region-specific activities of insulin in the CNS; that is, there is an anatomical context to the role of insulin in the brain. This feature is shared by many peptides acting in the CNS, particularly peripherally-derived peptides like insulin, GLP-1, leptin and ghrelin (among others). Similarly, there is also a temporal context to the activities of insulin in the CNS. For example, acute administration of exogenous insulin rapidly facilitates synaptic plasticity, whereas more gradual and prolonged physiological changes in insulin tone create an environment upon which neuroplasticity occurs.

Any discussion of the temporal context of insulin activity must also include insulin resistance, which ultimately contributes to neuroplasticity deficits in metabolic disorders like obesity and type 2 diabetes mellitus (T2DM). The progressive dysregulation of insulin is one of the primary features of obesity and T2DM, leading researchers to examine the effects of insulin on the function of hippocampal and mesocorticolimibic circuits that underlie cognitive and motivational processes. In this framework, the CNS activities of insulin could be conceptualized as a continuum in which insulin promotes neuroplasticity as an integral part of healthy brain function which then becomes dysregulated alongside the development of obesity, T2DM and associated complications such as neuroinflammation. Indeed, the clinical and preclinical data to date suggest that the ability of insulin to influence neural activity breaks down as a result of metabolic stress and the physiological alterations that accompany obesity (see [Fig. 1](#F1){ref-type="fig"}).

In view of these observations, the goals of this review are to provide an overview of our current understanding of the role insulin plays in neural plasticity, cognition, and motivation from a temporal, anatomical, and functional perspective. We begin by discussing the neural and behavioral actions of insulin in the hippocampus and the role of hippocampal insulin resistance in cognitive deficits associated with obesity. We then discuss the emerging literature examining insulin activity in "motivation" centers like the nucleus accumbens (NAc) and ventral tegmental area (VTA).

2. Anatomical and temporal context of insulin activity in the CNS: hippocampal-dependent behaviors {#S2}
==================================================================================================

Molecular and pharmacological approaches have determined that insulin receptor mRNA and protein are widely expressed in the CNS ([@R38]; [@R34]; [@R31]; [@R80]; [@R50]). From a temporal perspective, the highest expression of CNS insulin receptors occurs during the early stages of development. During these periods insulin receptors are proposed to play in critical roles in neuronal maturation, neurogenesis and synaptogenesis (for review see ([@R14])). From an anatomical perspective, insulin regulates very different physiological and behavioral responses depending upon which receptor populations are activated. For example, one of the first reports describing the activities of insulin in the CNS came from Woods and coworkers indicating that intracerebral administration of insulin decreased food intake and body weight in baboons ([@R90]). Subsequent studies by many investigators determined that these effects of insulin on metabolism and body weight were mediated by insulin receptors expressed in the hypothalamus \[for review see ([@R67])\] and more recent analyses have focused on the hypothalamic circuitry involved in these processes ([@R89]).

Interestingly, hippocampal insulin receptors have been shown to have distinct functional roles vis-à-vis hypothalamic receptors; namely, hippocampal insulin receptors are known to regulate structural and functional plasticity, and to enhance cognition ([@R20]). For example, while an early study reported that insulin impaired behavior in the passive avoidance test ([@R68]), subsequent studies reported that icv insulin administration enhanced behavior in this test ([@R62]). Closer examination of these disparate results provide an example of the temporal context of insulin activity in that administration of insulin preceding retention testing reduced avoidance latency ([@R68]), while administration prior to training enhanced avoidance latency ([@R62]). More recent studies demonstrated that intra-hippocampal administration of insulin enhances spatial learning in a dose-dependent manner ([@R53]; [@R56], [@R55]). Consistent with the clinical literature \[see ([@R8]; [@R17]) for examples\] intranasal insulin enhances behavioral performance in aged F344 rats, effects that were dependent upon both insulin formulation (i.e. short-acting versus long-acting) and dose ([@R48]). Additionally, it is interesting to note the bidirectional relationship between learning and memory and insulin receptor signaling. For example, studies by Alkon and coworkers have shown that spatial training in the water maze increases hippocampal insulin receptor expression and signaling ([@R92]). From an anatomical and temporal context at the synaptic level, insulin may mediate these pro-cognitive activities through modulation of the expression and activity of classic neurotransmitter systems, in particular the glutamatergic system [Fig. 1](#F1){ref-type="fig"}).

2.1. Temporal context of insulin activity: facilitation of synaptic plasticity at hippocampal synapses {#S3}
------------------------------------------------------------------------------------------------------

One of the first examples of insulin-mediated potentiation of glutamatergic neurotransmission examined the ability of insulin to facilitate NMDA receptor-mediated transmission in oocyte expression systems, as well as in hippocampal slice preparations. In this regard, brief application of insulin transiently potentiated NMDA currents, responses that were attenuated by the PKC inhibitor staurosporine ([@R46]). Subsequent studies by these same investigators revealed that insulin elicits robust and transient increases in tyrosine phosphorylation of NR2A and NR2B subunits ([@R15]). Other studies similarly reported that insulin enhanced NMDA-mediated currents in a dose- and time-dependent manner, and that insulin facilitation of NMDA currents was attenuated by tyrosine kinase inhibitors ([@R13]). At the synaptic level, these insulin-mediated effects likely result from exocytotic delivery of NMDA receptors to the membrane surface ([@R71]). Collectively these studies supported the concept that insulin receptor signaling enhances NMDA-mediated glutamatergic neurotransmission in the hippocampus.

Studies have also examined the effects of exogenous insulin administration on AMPA-receptor (AMPAR) mediated glutamatergic transmission, and interestingly these studies identified different functional outcomes when compared to studies that examined insulin/NMDA receptors relationships. For example, insulin stimulated internalization of GluA2-containing AMPARs in hippocampal primary cultures ([@R7]; [@R49]). These results are consistent with an earlier report that insulin dose-dependently decreased the spontaneous firing rates of hippocampal pyramidal neurons ([@R60]). Subsequent studies determined that insulin-induced internalization of hippocampal AMPARs was tyrosine kinase dependent and identified the tyrosine residues required for insulin-stimulated endocytosis ([@R2]; [@R45]). Additional studies examined the contribution of cytoskeletal changes to AMPAR subunit internalization ([@R93]) and identified the subcellular compartmentalization of GluA1 and GluA2 subunits in response to insulin treatment in hippocampal primary neuronal cultures ([@R45]). From a functional perspective, these synaptic changes elicited by insulin administration were associated with induction of LTD in the CA1 region of the hippocampus ([@R2]; [@R49]). At the time, rather little was known about how AMPAR subunit composition affected the trafficking of the receptors, and these studies provided evidence for differential regulation of GluA1/2 vs GluA2/3-containing AMPARs and the role of AMPAR subunit phosphorylation in trafficking of the receptor. Thus, in these early studies, insulin was predominantly used as a tool to understand the mechanisms of AMPAR trafficking and plasticity. However, the physiological relevance of the results was only cautiously interpreted in the context of neuronal development and maturation.

The results described above provide seemingly dissimilar views of the effects of insulin on glutamatergic function in hippocampal synapses. Specifically, some studies reported that insulin induces LTD and produces AMPAR endocytosis ([@R7]; [@R45]; [@R49]; [@R2]; [@R35]), while other studies reported that insulin elicits LTP and enhances membrane trafficking of glutamate receptor subunits ([@R13]; [@R46]; [@R71]). However, the differential trafficking and plasticity rules governing AMPA receptor sub-types may account for these differences. Specifically, AMPARs comprised of GluA1/GluA2 subunits move in and out of the synapse in an activity dependent manner that relies in part on phosphorylation of serine residues on the intracellular tail of GluA1, while GluA2/GluA3 containing AMPA receptors constitutively recycle in and out of the synapse ([@R36]). In addition, a third population of GluA2-lacking AMPA receptors (GluA1/GluA1 or GluA1/GluA3) is also subject to activity-dependent synaptic insertion and removal. Although less well-understood, these receptors are abundant during early development and are up-regulated in response to consumption of sugary, fatty foods as well as food restriction in adults ([@R11]; [@R23]; [@R59]; [@R63]). In the hippocampal studies described above, insulin-induced reductions in AMPAR surface expression were predominantly mediated by the removal of GluA2-containing AMPARs, whereas insulin-induced increases in AMPAR surface expression were predominantly mediated by the addition of GluA1-containing AMPARs (GluA1/GluA2 or GluA1/GluA1). Thus, it is possible that insulin may have distinct effects on GluA1-vs. GluA2-containing AMPA receptors, although this has not been directly tested.

Another consideration is how experimental context may influence insulin-induced glutamatergic plasticity. For example, a study by Ramakers and coworkers determined that insulin tone can also influence subsequent hippocampal synaptic plasticity ([@R81]). In this study, bath application of insulin produced a rightward shift in the frequency response curve, such that a reduced stimulus intensity was required for the induction of LTP in the CA1 region of the hippocampus. This study also determined that these effects of insulin were NMDA dependent. When placed in the broader functional context, these data illustrate that insulin elicits dynamic effects on glutamatergic synaptic transmission that can be dependent on the insulin tone present.

Beyond excitatory neurotransmission, a more limited number of studies have examined the ability of insulin to modulate the GABAergic system. Similar to observations in NMDA and AMPARs, insulin stimulates the trafficking of GABA~A~ receptor subunits from an intracellular compartment to the membrane surface in transfected HEK cells and in primary hippocampal neuronal cultures, resulting in an increase in mIPSCs ([@R84]). More recent studies reported that insulin shifts tonic GABAergic currents in the CA1 region of the hippocampus, an effect that was suggested to result from the recruitment of high affinity GABA~A~ receptors ([@R37]). The ability of insulin to alter excitatory and inhibitory neurotransmission has important functional implications for hippocampal transmission and plasticity. However, understanding the net effect of insulin on neurotransmission is challenging, as the studies described above require use of receptor antagonists in order to isolate the activity of the receptor of interest (i.e. bath application of the GABA~A~ receptor antagonist bicuculline to measure EPSPs). When placed in the anatomical context of the *in vivo* synapse, it is interesting to speculate that insulin facilitates excitatory neurotransmission by decreasing the threshold required for induction of LTP and by stimulating changes in NMDA and AMPAR subunit composition and activity, while effects on GABA~A~ receptors may assist in the coordination of glutamatergic transmission in excitatory pyramidal neurons.

2.2. Insights from molecular approaches to induce brain insulin resistance {#S4}
--------------------------------------------------------------------------

Studies from experimental models of diabetes and obesity support the concept that insulin facilitates hippocampal synaptic plasticity ([@R9]). For example, deficits in hippocampal neuroplasticity that include impairments in learning and memory are observed in streptozotocin (STZ)-treated rodents, rodents provided a high fat diet, and rodents with genetic mutations that result in an obesity/T2DM phenotype such as *ob/ob* mice, *db/db* mice and Zucker rats ([@R20]). However, one of the major limitations of these studies is that these rodents do not exclusively exhibit brain insulin resistance, but rather exhibit all the hallmark features of metabolic disorders, including peripheral insulin resistance and glucose intolerance. Even studies employing molecular approaches to selectively target brain insulin receptor signaling have suffered from these limitations. In this regard, while insulin receptor substrate 2 knockout mice exhibit reductions in glutamatergic neurotransmission in the CA1 region of the hippocampus ([@R51]), these mice also exhibit metabolic abnormalities that include peripheral insulin resistance and impaired glucose tolerance ([@R86]). Similarly, mice with neuron-specific deletion of the insulin receptor (NIRKO) exhibit endocrine and metabolic deficits that include increases in body weight and body adiposity, as well as increases in plasma leptin and triglyceride levels ([@R10]). Collectively, these studies emphasize the challenges to disentangling the specific role of brain insulin receptor activity in synaptic plasticity independent of peripheral insulin activity.

Fortunately, a number of recent studies have examined how brain insulin resistance impacts hippocampal synaptic plasticity independent of peripheral metabolic and endocrine changes. In this regard, heterozygous insulin receptor knockout mice, which clear glucose as effectively as wild type mice in response to an oral glucose tolerance test ([@R1]), exhibit deficits in high frequency stimulation-induced LTP in the hippocampus, as well as behavioral deficits as assessed in the novel object recognition test ([@R57]). More recently, we have shown that hippocampal-specific insulin resistance induced through selective antisense-mediated knock down of hippocampal insulin receptors impairs hippocampal synaptic plasticity in the absence of peripheral metabolic or endocrine impairments ([@R29]). Specifically, rats with hippocampal-specific insulin resistance exhibited impairments in high frequency stimulated LTP that were associated with decreases in the expression and phosphorylation of glutamate receptor subunits. Additionally, rats with hippocampal-specific insulin resistance exhibited spatial learning and memory deficits, as assessed in the water maze. The results from this study support the concept that hippocampal insulin resistance can occur independently of peripheral insulin resistance and thereby contribute to neuroplasticity deficits in metabolic disorders. In addition, these data suggest that the hippocampus may be a locus responsible for the pro-cognitive effects of intranasal insulin administration.

3. Actions of insulin in mesocorticolimbic systems {#S5}
==================================================

As stated in the introduction, the unabated growth of the obesity epidemic and the revelation that cognitive decline, depression, and anxiety can all be exacerbated, and likely induced, by obesity have invigorated studies of the role of insulin in adult brain. It is well established that mesolimbic circuits act as an interface between emotional and motivational states to direct behavior towards and away from primary rewards like food ([@R12]; [@R39]; [@R40]; [@R69]). Thus, mesolimbic circuits are involved in a wide array of complex behaviors from Pavlovian and instrumental learning, to decision making and the encoding of value. For the purposes of this review, we will focus on the neural and behavioral effects of insulin administration in the nucleus accubmens (NAc) and ventral tegmental area (VTA). Insulin receptors are expressed in the NAc and VTA, and insulin from the periphery readily reaches striatal regions ([@R5]). However, to date only a handful of studies have examined the effects of insulin on neurotransmission in these regions (see also [Table 1](#T1){ref-type="table"}).

3.1. Anatomical context of insulin in the NAc {#S6}
---------------------------------------------

Insulin receptors are moderately abundant in the NAc compared to other brain regions ([@R38]). Within the NAc, 85--90% of neurons are GABAergic medium spiny projection neurons (MSNs), while the remaining 10--15% of neurons are comprised cholinergic, parvalbumin fast-spiking GABAergic, and somatostatin and nitric oxide synthetase-containing GABAergic interneurons that regulate presynaptic transmitter release as well as MSN excitability ([@R85]). The NAc can be further divided into core and shell subregions that have distinct anatomical inputs and roles in feeding-related behaviors ([@R41]; [@R91]). However, given the limited number of studies that have been conducted, we will not discuss core/shell differences below, but will note when studies have differentiated between these subregions.

Insulin receptors are located on cholinergic interneurons and on MSNs, but are not thought to be located on other cells within the NAc, or on presynaptic terminals within the region ([@R26]). Insulin receptor function has been extensively reviewed ([@R22]) and thus detailed information will not be reiterated here. However, it is worthwhile to note that insulin can be promiscuous, binding to and activating insulin-like growth factor receptors (IGFR), as well as hybrid receptors comprised of insulin receptor subunits and IGFR subunits ([@R82]). The degree of activation varies as a function of insulin concentration, with \~100 fold difference in sensitivity of IRs vs. IGFRs to insulin ([@R65]). Both receptor populations are expressed within the NAc and VTA; thus, careful pharmacological studies that include receptor specific antagonists are needed to confirm that effects of insulin are due to insulin receptor vs. IGFR activation ([@R64]).

3.2. Temporal context: effects of insulin on synaptic transmission in the NAc {#S7}
-----------------------------------------------------------------------------

Some recent studies by our group have examined the effect of insulin on excitatory transmission in the NAc ([@R58]). For these studies acute brain slices containing the striatum were prepared from adult, male rats and whole-cell patch-clamp recordings of evoked EPSCs (eEPSCs) were made from MSNs before and after bath application of insulin (1--500 nM). Similar to some results in hippocampus, insulin receptor activation enhanced excitatory transmission in the NAc core (10, 30 nM). This effect was blocked by co-application of an insulin receptor antagonist and was due to an increase in presynaptic glutamate release as measured by paired pulse facilitation and increases in mEPSC frequency. Furthermore, blockade of insulin receptor signaling only within the recorded MSN was sufficient to prevent insulin\'s effects on excitatory transmission, suggesting that there is a retrograde feedback signal to reduce glutamate release. However, unlike the hippocampus (above) and VTA (see below), where effects of insulin are long-lasting, effects of insulin on excitatory transmission within the NAc were rapidly and completely reversed by insulin wash out. In addition, increasing the concentration of insulin to 100 nM recruited activation of IGFRs and produced an opposing decrease in excitatory transmission. This dynamic and bidirectional response to insulin may enable the NAc to be particularly sensitive to shifts in insulin levels and allow for the rapid regulation of excitatory transmission (see below on NAc insulin and behavior).

One caveat to the bidirectional actions of insulin described above is that physiological concentrations of insulin are thought to remain below 30 nM. However, this idea is based on a limited number of studies measuring insulin levels in CSF, plasma, or brain homogenates ([@R5]; [@R32]; [@R76]; [@R83]). In addition, no direct studies of NAc insulin levels, particularly after a high-sugar/high-fat meal or chronic hyperinsulinemic states, have been conducted. Thus, the true dynamic range of insulin in non-obese, and obese states remains to be be determined. However, it is clear that alterations in peripheral insulin levels, either through acute or chronic diet manipulation, affect the ability of insulin to modulate neuronal function in several brain regions including the NAc. For example, we also found that free access to a 60% high-fat diet for 8 weeks induced obesity that was accompanied by elevations in fasted insulin levels. When recordings were made from MSNs in the NAc core of these rats, insulin-induced increases in excitatory transmission following 30 nM insulin were completely lost. This was accompanied by a decrease in insulin receptor surface expression in the NAc. These data are consistent with deficits in hippocampal neuroplasticity after diet-induced obesity discussed above. However, whether brain insulin resistance in the NAc occurs prior to peripheral insulin resistance, as has been established for the hippocampus, is unknown.

In addition to effects on glutamatergic transmission described above, one recent study showed that insulin also indirectly alters dopamine transmission within the NAc core and shell ([@R75]). Specifically, [@R75] used whole-cell recordings and voltammetry in acute brain slices to examine alterations in cholinergic interneuron activity and evoked dopamine release following bath application of insulin. They found that insulin receptor activation enhanced activity of cholinergic interneurons, thereby enhancing dopamine release at the level of presynaptic terminals within the NAc. Interestingly, this effect was seen at concentrations of insulin up to 30 nM, but was absent at higher concentrations. This is consistent with the sensitivity of insulin receptors to insulin, and suggests that basal insulin tone in the brain may alter insulin\'s effects on striatal dopamine.

The ability of insulin receptor activation to enhance dopamine release was somewhat surprising given that insulin treatment in *ex vivo* slices has also been found to enhance dopamine transporter function in the NAc ([@R18]; [@R73]), and to reduce excitatory drive to VTA dopamine neurons that terminate in the NAc ([@R43]; see also below). However, data from behavioral studies are consistent with an overall facilitation of NAc activity by insulin, and with a role for NAc insulin in enhanced reinforcement (see section 3.3). Thus, although insulin may have varying and potentially competing effects within mesolimbic circuits and micro-domains within the NAc, data to date suggest that the net effect of insulin receptor activation in the NAc is to enhance both dopaminergic and glutamatergic transmission (see ([@R75]) for additional discussion).

When trying to integrate the temporal context of insulin\'s effects on NAc dopamine vs. pre-synaptic glutamate release it\'s important to consider the timescales on which these effects occur. Effects of insulin on local dopamine release emerge \~20 min after insulin application, whereas effects on MSN excitatory transmission are immediately apparent and reach a maximum within \~7 min. Thus, the temporal profile of increases in insulin, as well as the concentration of insulin achieved, may dramatically influence the net effect of insulin on transmission within the NAc (see also [Table 1](#T1){ref-type="table"}).

3.3. Effects of NAc insulin on feeding-related behavior {#S8}
-------------------------------------------------------

While it\'s well-accepted that central actions of insulin influence feeding behavior, the nature of this effect and the underlying mechanisms are poorly understood ([@R25]). In two elegant studies, Carr and colleagues have shown that insulin administered directly into the NAc shell reduces preference for glucose containing solutions ([@R75]; [@R88]). For these studies they used two different flavor-nutrient preference learning procedures in which distinct flavors were paired with glucose solution. Consumption of glucose results in a rapid rise in peripheral and central insulin. Thus, they reasoned that glucose consumption itself would enhance endogenous insulin brain levels, and that affects downstream of this increase could be prevented by pairing a given solution with blockade of insulin signaling in the NAc shell. In their first study, two different flavors were paired with the same glucose concentration (0.8%; [@R75]). Controls received mock infusions or vehicle prior to exposure to each solution; this resulted in no preference between the two flavors when sucrose was omitted from the solution. In experimental animals, an antibody against insulin was infused directly into the NAc shell just prior to consumption of one flavored 0.8% glucose solution, while a distinct flavor was paired with mock infusion and the same 0.8% glucose. Under these conditions, rats consumed less of the flavored solution that was paired with insulin antibody infusion, showing that blockade of insulin signaling within the shell was sufficient to reduce preference for the insulin-antibody paired solution ([@R75]). In a follow-up study, they took a slightly different approach in which rats were trained to associate one flavor with low glucose (1%), and another flavor with high glucose (6.1%). In controls, this resulted in a preference for the flavor that was previously paired with high glucose. However, when the high glucose solution was paired with intra-NAc shell insulin antibody infusion during initial training, the subsequent expression of a preference for the high glucose paired flavor was abolished ([@R88]). Together these data suggest that actions of insulin within the NAc shell influence the reinforcing properties of nutritive value. Importantly, glucose consumption increased insulin receptor phosphorylation, indicative of insulin receptor activation, and infusion of the insulin receptor antibody prevented this change ([@R88]). Interestingly, the reduction in preference for the insulin antibody paired flavors was apparent both during initial training and during flavor preference testing in which glucose was omitted. Thus, manipulation of insulin affected both the acquisition of the initial preference, as well as its expression. Furthermore, the magnitude of insulin receptor phosphorylation in the NAc (core and shell combined) was greater following consumption of high vs. low sucrose-containing solutions. This change occurred within 7 min of sucrose consumption and provides a potential mechanism by which the NAc may "sense" sugar consumption.

The results described above are from ad lib fed male rats. Although comparable studies of the effect of intra-NAc insulin blockade were not conducted in obese rats, flavor preference for high vs. low sucrose-paired flavors was lost following diet-induced obesity ([@R88]). This is consistent with a loss of neural insulin sensitivity following high-fat diet consumption described for the hippocampus and NAc, and led Woods and colleagues to conclude that, "obese individuals, with insulin insensitivity, may make food choice based on inaccurate nutritive assessments." ([@R88]; pg 61). While it\'s unclear how this would explain a continued preference for high sugar containing foods observed in many obese individuals, it may help explain in part the initial establishment of preferences for sweeter foods and for the escalation in consumption of increasingly sweeter foods in obesity. However, for the latter to be true one would have to posit that neural insulin insensitivity could be over-come by consumption of sufficiently high concentrations of glucose. To date no such evidence suggests that this is the case. Another possibility is that insulin in the NAc plays a role in establishing nutritive value, particularly in relation to the sensory properties of foods that are paired with glucose. However, once neural insulin resistance develops the ability to shift these established preferences and conditioned responses may be reduced, thereby perpetuating unhealthy food choices. Of course additional studies are needed to determine if this is the case.

3.4. What are the potential mechanisms underlying behavioral effects of intra-NAc insulin? {#S9}
------------------------------------------------------------------------------------------

While the specific mechanism underlying the role of NAc insulin in flavor nutrient learning is not known, the ability of insulin to enhance striatal dopamine and glutamate likely play a role (see also [@R88] for discussion). As stated above, application of insulin in the NAc enhances local dopamine release in the NAc core and shell ([@R75]), and data from our lab show that insulin receptor activation increases excitatory transmission onto MSNs in the NAc core ([@R58]). Thus, it is tempting to speculate that elevations in insulin result in coordinated actions of dopamine and glutamate to promote plasticity that underlies the reinforcing properties of foods high in sugar. Consistent with this idea, intra-gastric infusion or oral consumption of glucose (16%) is sufficient to enhance GluA1s845 phosphorylation in the NAc within 7 min ([@R88]). Phosphorylation of this serine residue results in the priming of GluA1-containing AMPARs for synaptic insertion, enhances single-channel conductance, and is mediated by PKA activity ([@R44]; [@R72]). Furthermore, activation of D1-type dopamine receptors increases AMPAR surface expression in NAc MSNs via activation of PKA and phosphorylation of s845 on GluA1 ([@R77]; [@R87]). Thus, enhanced GluA1s845 phosphorylation following glucose consumption may be mediated in part by insulin-induced increases in dopamine. One caveat to this interpretation is that the time course of insulin\'s effects on dopamine release and GluA1s845 phosphorylation differs. Specifically, insulin-induced increases in local dopamine release in acute brain slices occur \~20 min after insulin application, whereas increases in GluA1s845 phosphorylation were found within 7, but not 17, minutes after *in vivo* glucose consumption. However, increases in glutamatergic transmission following insulin application were immediately apparent, supporting the idea that insulin is tapping into plasticity mechanisms. Of course, these temporal differences in the response to insulin could reflect differences in physiological vs. pharmacological manipulation of insulin signaling, and caution must be taken when attempting to integrate data from *ex vivo* and *in vivo* approaches. None-the-less, given the prominent role of striatal dopamine and glutamate in reinforcement and motivation for food, the data available provide strong support of the regulation of striatal motivational circuits by insulin.

3.5. Effects of insulin on synaptic transmission within the VTA {#S10}
---------------------------------------------------------------

Only two studies have examined effects of insulin on excitatory neurotransmission within the VTA. This work from Borgland and colleagues using acute slices in young male mice showed that bath application of insulin reduces presynaptic glutamate release and leads to a long-lasting depression of excitatory transmission onto VTA dopamine neurons ([@R43]; [@R47]). This effect of insulin was concentration dependent, with modest but appreciable reductions following 1 or 10 nM insulin and more pronounced reductions following 100 or 500 nM insulin (\~40% of baseline). This LTD was due to retrograde endocannabinoid feedback, and was blocked by insulin receptor, but not IGFR antagonists. The latter is important because these studies predominantly used 100 nM insulin, a concentration that can produce IGFR activation. Thus, although IGFRs are located in the VTA, effects of insulin on excitatory transmission in this brain region appear to be limited to insulin receptor activation, unlike in the NAc.

The onset of insulin\'s effects in VTA were fairly rapid, consistent with effects on excitatory transmission in the NAc, and with time scales needed to regulate ongoing food intake (see below for VTA-insulin and behavior). While insulin induced LTD may seem at odds with the increases in local NAc dopamine release following insulin discussed above, it\'s unlikely that the effects of insulin on VTA dopamine neurons represent a simple all or none change in firing. Instead, Borgland and colleagues suggest that reductions in excitatory drive induced by insulin may reduce the probability of burst-firing, and thereby influence feeding behavior ([@R54]); see also [Fig. 2](#F2){ref-type="fig"}.

The effect of acute food consumption, which is expected to increase endogenous insulin, on subsequent neural responses to insulin application were also examined in the studies described above. Specifically, when mice were allowed to eat sweetened high fat (SHF) food immediately prior to slice preparation, insulin-induced reductions in excitatory transmission were completely absent ([@R47]). Although indirect, this suggests that physiological increases in insulin induced by SHF food consumption occluded the effect of subsequent bath application of insulin. To date, no studies have determined how diet-induced obesity or chronic consumption of SHF foods may alter insulin\'s ability to influence excitatory transmission in the VTA. However, in BTBR Tþ Itpr3tf/J (BTBR) mice (which are hyperinsulinemic) insulin\'s capacity to induce LTD in VTA dopamine neurons was reduced ([@R47]). Importantly, both low-frequency stimulation- and cannabinoid-induced LTD were normal, suggesting that the blunted response to insulin was not due to overall deficits in VTA plasticity. Although this mutation causes a number of alterations to peripheral metabolism, the data are none-the-less consistent with the loss of insulin sensitivity associated with diet-induced obesity in other brain regions described above.

3.6. How does intra-VTA insulin affect feeding behavior? {#S11}
--------------------------------------------------------

Effects of intra VTA insulin on instrumental responding for food, and on the reinforcing properties of food using conditioned place preference (CPP) have been examined ([@R43]; [@R25]). Interestingly, intra-VTA insulin did not alter break point (i.e., the maximum number of responses an animal is willing to make to receive a given reinforcer) for either liquid sucrose or sweetened condensed milk, but did prevent the expression of CPP for a sweet treat \[Froot Loops ([@R43])\]. The latter is consistent with reductions in food CPP following i.c.v. insulin ([@R24]), and may reflect reductions in homoestatic drive where insulin may act more as a satiety signal. However, if this is the case, it is unclear why intra-VTA insulin did not also reduce motivation for food during progressive ratio testing, even when similar concentrations of insulin were used (2 µM). In addition, because insulin was only given during the final test for CPP or motivation, and not during initial acquisition of either task, the potential ability of insulin in the VTA to modulate initial learning of nutritive value remains unclear.

In hungry male mice, intra-VTA administration of insulin did not alter consumption of standard lab chow within a 4 h period, but did reduce consumption of a sweetened high-fat food ([@R54]). In this set of studies, mice were only allowed to eat their daily chow within one 4 h period outside the home cage each day. Thus, the absence of effects of insulin on chow consumption within that 4 h period may be influenced by this feeding schedule. For example, patterned feeding of this kind can induce conditioned anticipatory increases in peripheral insulin that may have occluded additional effects of intra-VTA insulin ([@R70]; [@R78]). Furthermore, the effect of insulin on consumption of sweetened high-fat food was measured after a 4 h chow feeding period. Thus, the authors concluded that insulin-induced reductions in the amount of sweetened high-fat food consumed reflected a blunting of hedonic feeding, as mice had already been sated on chow. These data are generally consistent with the ability of insulin to reduce excitatory drive to the VTA (see above), and with the generally anorectic effects of insulin in other brain regions. However, one additional caveat to interpretation is the fairly wide range of insulin concentrations used (e.g., 2 µM for break point for sucrose, 100 µM for break point for sweetened condensed milk). In sum, although the physiological role of insulin\'s actions in the VTA are not yet clear, studies to date do support a role for VTA insulin in feeding, particularly of sugary, calorie dense foods.

4. Summary, perspectives and gaps in our understanding {#S12}
======================================================

Our understanding of the actions of insulin in the CNS has progressed rapidly from the notion that the brain is an insulin-insensitive organ to our current appreciation that insulin promotes neuroplasticity and is integral to learning, cognition, and motivation. Although substantial progress has been made, there are many gaps in our knowledge base. In this regard, while studies have shown that intravenously administered insulin is detected in the brain parenchyma ([@R4]) and regional brain analysis of the distribution of radiolabeled insulin identified high levels of blood-borne insulin in the hippocampus and striatum ([@R5]), critical questions remain to be answered ([@R27]). For example, what are the *in vivo* synaptic concentrations of insulin under physiological conditions both before and after a meal? Are chronic elevations in peripheral insulin, such as those occurring during obesity, directly reflected in brain insulin levels? What is the temporal relationship between fluctuations in peripheral and central insulin? How does degree and duration of peripheral insulin dysregulation affect actions of insulin on neural plasticity?

Gaining insight into synaptic concentrations of insulin under different conditions has important functional implications. For example, effects of insulin on mesolimbic systems are concentration dependent. This may allow for the tuning of activity in these circuits such that relatively small increases in insulin in anticipation of a meal may enhance activity in striatal regions to facilitate food-seeking, while larger post-prandial elevations may reduce dopamine activity in VTA to reduce feeding ([Fig. 2](#F2){ref-type="fig"}). Moreover, while the studies described above clearly demonstrate that insulin rapidly alters glutamatergic transmission, the neuronal localization of insulin receptors vis-à -vis NMDA and AMPA receptors remains to be equivocally identified.

Beyond these questions related to anatomical context, questions of temporal context regarding insulin activity across the lifespan remain to be fully addressed and understood. Indeed, insulin enhancement of plasticity likely begins during development, as autoradiographic studies of insulin receptor binding indicate that insulin receptor expression is higher in neonates and gradually decreases into adulthood ([@R38]), and insulin is involved in neuronal differentiation and development ([@R14]). Furthermore, while none of the studies above examined effects of insulin in females, substantial evidence from clinical and preclinical studies of polycystic ovary syndrome and the effects of gestational diabetes on metabolism and development strongly suggest that there are likely sex differences in the physiological role of insulin in neural plasticity.

While the current review focused on the actions of insulin on neuronal activity, insulin activity has also been described in astrocytes. For example, from a developmental perspective insulin stimulates the differentiation of fetal hypothalamic stem cells towards an astrocytic phenotype ([@R19]). From a functional perspective, an early study reported that insulin receptors are expressed in rat primary glial cells and function to regulate glucose uptake ([@R16]). More recent studies suggest that insulin does not regulate glucose uptake, but rather stimulates glycogen production in cultured human astrocytes ([@R33]). Given the functional relationships between insulin and IGF-I described above, it is interesting to note that insulin combined with IGF-I increases glucose uptake in hippocampal/cortical primary astroglial cultures ([@R21]). While all these studies and others ([@R30]; [@R42]) suggest important roles for insulin in astrocytic metabolic function, one caveat associated with these studies is that they were performed in primary cultures. As such, an important future direction will be to replicate these provocative findings to the *in vivo* setting.

With regard to decreases in insulin receptor activity, insulin resistance, and the progression of age-related cognitive decline ([@R9]), the success of intranasal insulin administration to enhance cognitive function in patients with Alzheimer\'s disease (AD) ([@R17]) indicate that insulin resistance is perhaps a reversible pathophysiological feature of AD. Such results suggest that interventions to enhance brain insulin activity may be beneficial at many different time points along the continuum from normal brain aging to AD. Furthermore, while it\'s clear that insulin plays important roles in feeding, the nature and extent of this role, as well as how it is affected by obesity and T2DM is poorly understood. This is a particularly pressing problem given the potentially synergistic relationships between obesity and cognitive decline. Interestingly, one recent study in humans found that intra-nasal insulin was sufficient to reduce ratings of food-preference and this behavioral effect was associated with *reduced* activations in the NAc and VTA of people with normal insulin sensitivity. In contrast, intra-nasal insulin produced an *increase* in activations of these regions in subjects identified as overweight and insulin resistant. In these same individuals, intra-nasal insulin produced trends for *increased* food-preference scores (p = 0.09); ([@R79]). While it is difficult to directly determine causal relationships in studies like these, the data clearly indicate that intra-nasal insulin modulates food preference and activations of mesolimbic regions, and that this regulation is disrupted at the behavioral and neural level in insulin-resistant states. Thus, continuing to examine the effects of insulin on neural function and behavior in model systems and human studies will be critical to forming a complete understanding of the role of central insulin in physiological and pathophysiological states.

Finally, it is also possible that there may be two modes of insulin action that might differentially impact these brain regions: one that\'s circadian that may act more as a modulator of meta-plasticity, and another where larger more rapid changes occurring post-prandially drive traditional plasticity involved in learning and memory. Of course, only through continued examination of insulin\'s function in normal and disease states will we begin to understand its physiological role, as well as how we can harness its actions for potential therapeutic benefit.
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![Continuum of insulin effects on neuronal plasticity across a temporal/developmental context\
While glucose utilization in the CNS is likely to be largely insulin independent, the brain is not an insulin insensitive organ. Rather, insulin promotes neuroplasticity across development in the CNS in a variety of ways ranging from neuronal maturation to behavior. As depicted by the green insulin receptors and arrows in the upper panel, insulin facilitates plasticity at the synaptic level by regulating the expression and phosphorylation of glutamate receptors in the hippocampus and also coordinates the activity of mesolimbic networks. These activities of insulin are proposed to result in enhancement of synaptic transmission, as depicted by the green traces indicating enhancement of excitatory post-synaptic potentials (EPSPs). These activities provide examples of the anatomical and temporal contexts of insulin signaling activity in the CNS. However, insulin resistance will result in decreases in the phosphorylation state of glutamate receptors, as well as decreases in EPSPs, as depicted in red insulin receptors and arrows. Under these conditions, insulin resistance associated with obesity and T2DM impairs the substrate on which synaptic plasticity takes place. In this way, insulin activity in the CNS can be thought of a continuum beginning with the facilitation of neuroplasticity during development into adulthood (as depicted by the green arrows in the bottom panel), which then may be followed by reductions in neuroplasticity resulting from insulin resistance (as depicted in the red arrows in the bottom panel). See text for details.](nihms927597f1){#F1}

![Proposed VTA-NAc circuit for insulin regulation of food pursuit\
Relatively low concentrations of insulin produce increased glutamate release in the NAc and enhance dopamine release in this region through actions on cholinergic interneurons. As insulin concentrations increase, activation of IGFRs is recruited, causing a reduction in glutamate release. In addition, at these higher concentrations, local dopamine release within the NAc is no longer enhanced, and instead insulin results in LTD of VTA-dopamine neurons. Thus, small anticipatory increases in insulin in response to stimuli associated with food may activate local NAc circuits to promote food pursuit, while larger post-prandial increases in insulin may reduce activity in the VTA and NAc to reduce the pursuit of food and promote feeding cessation.](nihms927597f2){#F2}

###### 

Summary of effects of insulin on NAc and VTA excitatory transmission.

  Reference   Region            Measure            Direction of change   Ins Con                           Timing
  ----------- ----------------- ------------------ --------------------- --------------------------------- ------------------------------------------------
  [@R47]      VTA               eEPSC amp          ↓                     500 nM                            immediate onset, long-lasting
                                                                                                           
  [@R43]      VTA               eEPSC amp          ↓                     1, 10, 100, 500 nM; IC~50~ = 17   immediate onset, long-lasting
                                mEPSC freq         ↓                     500 nM                            not reported
                                PPR                ↑                     500 nM                            not reported
                                mEPSC amp          no change             500 nM                            not reported
                                                                                                           
  [@R75]      NAc Core          evoked \[DA\]~o~   ↑                     EC~50~ = 2 nM                     delayed onset (20 min) maximal at \~40--50 min
              NAc Shell         evoked \[DA\]~o~   ↑                     EC~50~ = 5 nM                     not reported
              CPu               evoked \[DA\]~o~   ↑                     EC~50~ = 2.4 nM                   not reported
              NAc all regions   evoked \[DA\]~o~   no change             \>100 nM                          immediate onset, reversible
                                                                                                           
  [@R58]      NAc core          eEPSC amp          ↑                     10, 30 nM                         immediate onset, reversible
                                mEPSC freq         ↑                     30 nM                             
                                PPR                ↓                     30 nM                             
                                mEPSC amp          no change             30, 100 nM                        
                                eEPSC amp          ↓                     100--500 nM                       immediate onset, reversible
                                mEPSC freq         ↓                     500 nM                            
                                PPR                ↑                     500 nM                            
                                mEPSC amp          no change             500 nM                            
